NCT04020627

Brief Summary

Effectiveness of BIPAP is evaluated in Type-2 failure but evaluation of effectiveness of CPAP in Type-2 respiratory failure in post cardiac surgery patients was not done. So the objective of this study is to determine the acute effects of BIPAP vs. CPAP with conventional physiotherapy on Hemodynamics and Respiratory parameters in management of Type 2 Respiratory failure in post cardiac surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 13, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
Last Updated

July 16, 2019

Status Verified

July 1, 2019

Enrollment Period

4 months

First QC Date

July 13, 2019

Last Update Submit

July 13, 2019

Conditions

Keywords

Respiratory failureBiPapCPapRespiratory ParametersHemodynamics

Outcome Measures

Primary Outcomes (8)

  • Arterial blood gas (ABG) parameter like potential of hydrogen (PH)

    Above parameter was measured by serial ABG analysis. Its normal reference range is 7.35-7.45. baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline

    3rd Day

  • Arterial blood gas parameter like bicarbonate(HCO3).

    Above parameter was measured by serial ABG analysis. Its normal reference range is 22-28 nmol/L. Baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline

    3rd Day

  • Arterial blood gas parameter like partial pressure of carbon dioxide (PCO2)

    Above parameter was measured by serial ABG analysis. Its normal reference range is 35-45 mmHg. Baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline

    3rd Day

  • Arterial blood gas parameter like partial pressure of carbon dioxide (PO2)

    Above parameter was measured by serial ABG analysis. Its normal reference range is 80-100 mmHg. Baseline reading will be taken at 10 minutes before starting Non invasive ventilation training. Changes from the Baseline

    3rd Day

  • Heart Rate

    Changes from the Baseline, It will be measured through Cardiac Monitor

    3rd Day

  • Saturation (SPO2)

    Changes from the Baseline, It will be measured in percentage through Cardiac Monitor.

    3rd Day

  • Systolic Blood Pressure (SBP)

    Changes from the Baseline, It was measure through sphygmomanometer and Blood pressure is measured in units of millimeters of mercury (mmHg). The readings are always given in pairs, with the upper (systolic) value first, followed by the lower (diastolic) value.

    3rd day

  • Diastolic Blood Pressure (SBP)

    Changes from the Baseline, It was measure through sphygmomanometer and Blood pressure is measured in units of millimeters of mercury (mmHg). The readings are always given in pairs, with the upper (systolic) value first, followed by the lower (diastolic) value.

    3rd Day

Secondary Outcomes (2)

  • Richmond Agitation-Sedation Scale (RASS)

    3rd day

  • Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

    3rd Day

Study Arms (2)

BiPAP Group

EXPERIMENTAL

Bilevel Positive Airway Pressure

Other: BiPAP Group

CPAP Group

EXPERIMENTAL

Continuous Positive Airway Pressure

Other: CPAP Group

Interventions

BIPAP \- 1hr after every 6hrs for 3 days/week Conventional physiotherapy Treatment (Percussion, vibration, shaking) Modified postural drainage Incentive spirometer Blow bottle/Tissue blowing/Positive Expiratory Pressure(PEP) device

BiPAP Group

CPAP \- 1hr after every 6hrs for 3 days/week Conventional physiotherapy Treatment (Percussion, vibration, shaking) Modified postural drainage Incentive spirometer Blow bottle/Tissue blowing/PEP device

CPAP Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Type 2 respiratory Failure partial pressure of Oxygen(PaO2) of \<8 kilopascal(kPa) and pco2 of \>6 kpa with a respiratory acidosis pH\<7.35 (H+\>45nmol/L) guidelines provided by British Thoracic society.
  • Patients with Sleep apnea /acute confusional state (Psychosis)

You may not qualify if:

  • Person with Surgical Emphysema
  • Pneumothorax
  • Medically unstable (hypotensive shock, uncontrolled cardiac ischemia, or arrhythmia
  • Person with Bulla's disease
  • Severe bronchospasm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riphah International University

Islamabad, Federal, 44000, Pakistan

Location

Related Publications (8)

  • British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax. 2002 Mar;57(3):192-211. doi: 10.1136/thorax.57.3.192. No abstract available.

    PMID: 11867822BACKGROUND
  • Antonelli M, Conti G, Rocco M, Bufi M, De Blasi RA, Vivino G, Gasparetto A, Meduri GU. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med. 1998 Aug 13;339(7):429-35. doi: 10.1056/NEJM199808133390703.

    PMID: 9700176BACKGROUND
  • Pelosi P, Severgnini P, Aspesi M, Gamberoni C, Chiumello D, Fachinetti C, Introzzi L, Antonelli M, Chiaranda M. Non-invasive ventilation delivered by conventional interfaces and helmet in the emergency department. Eur J Emerg Med. 2003 Jun;10(2):79-86. doi: 10.1097/00063110-200306000-00002.

    PMID: 12789060BACKGROUND
  • Pieczkoski SM, Margarites AGF, Sbruzzi G. Noninvasive Ventilation During Immediate Postoperative Period in Cardiac Surgery Patients: Systematic Review and Meta-Analysis. Braz J Cardiovasc Surg. 2017 Jul-Aug;32(4):301-311. doi: 10.21470/1678-9741-2017-0032.

    PMID: 28977203BACKGROUND
  • Mehta Y, Vats M, Kumar SK, Singh S, Khurana P, Trehan N. Prevention of postoperative atelectasis in the post-cardiac surgical patient with poor left ventricular function: A study of the efficacy of Bi-level positive airway pressure. Chest. 2017 Oct 1;132(4):537A

    BACKGROUND
  • Olper L, Bignami E, Di Prima AL, Albini S, Nascimbene S, Cabrini L, Landoni G, Alfieri O. Continuous Positive Airway Pressure Versus Oxygen Therapy in the Cardiac Surgical Ward: A Randomized Trial. J Cardiothorac Vasc Anesth. 2017 Feb;31(1):115-121. doi: 10.1053/j.jvca.2016.08.007. Epub 2016 Aug 10.

    PMID: 27771274BACKGROUND
  • Barbe F, Togores B, Rubi M, Pons S, Maimo A, Agusti AG. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. Eur Respir J. 1996 Jun;9(6):1240-5. doi: 10.1183/09031936.96.09061240.

    PMID: 8804944BACKGROUND
  • Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003 Mar 27;348(13):1233-41. doi: 10.1056/NEJMoa022479.

    PMID: 12660387BACKGROUND

MeSH Terms

Conditions

HypoventilationRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Iqbal Tariq, MSCPPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2019

First Posted

July 16, 2019

Study Start

January 10, 2019

Primary Completion

May 10, 2019

Study Completion

June 10, 2019

Last Updated

July 16, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations